Ramsay Generale De Sante (GDS) - Net Assets
Based on the latest financial reports, Ramsay Generale De Sante (GDS) has net assets worth €1.17 Billion EUR (≈ $1.37 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€6.58 Billion ≈ $7.69 Billion USD) and total liabilities (€5.41 Billion ≈ $6.32 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore total assets of Ramsay Generale De Sante for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.17 Billion |
| % of Total Assets | 17.82% |
| Annual Growth Rate | 7.43% |
| 5-Year Change | 7.56% |
| 10-Year Change | 169.94% |
| Growth Volatility | 44.1 |
Ramsay Generale De Sante - Net Assets Trend (2005–2025)
This chart illustrates how Ramsay Generale De Sante's net assets have evolved over time, based on quarterly financial data. Check Ramsay Generale De Sante (GDS) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Ramsay Generale De Sante (2005–2025)
The table below shows the annual net assets of Ramsay Generale De Sante from 2005 to 2025. For live valuation and market cap data, see GDS stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | €1.18 Billion ≈ $1.38 Billion |
-3.90% |
| 2024-06-30 | €1.23 Billion ≈ $1.44 Billion |
-3.70% |
| 2023-06-30 | €1.28 Billion ≈ $1.49 Billion |
+3.08% |
| 2022-06-30 | €1.24 Billion ≈ $1.45 Billion |
+12.74% |
| 2021-06-30 | €1.10 Billion ≈ $1.28 Billion |
+5.93% |
| 2020-06-30 | €1.04 Billion ≈ $1.21 Billion |
-0.13% |
| 2019-06-30 | €1.04 Billion ≈ $1.21 Billion |
+103.23% |
| 2018-06-30 | €511.00 Million ≈ $597.41 Million |
+1.79% |
| 2017-06-30 | €502.00 Million ≈ $586.89 Million |
+14.66% |
| 2016-06-30 | €437.80 Million ≈ $511.83 Million |
+42.10% |
| 2015-06-30 | €308.10 Million ≈ $360.20 Million |
+3.46% |
| 2014-12-31 | €297.80 Million ≈ $348.16 Million |
-34.94% |
| 2014-06-30 | €457.70 Million ≈ $535.10 Million |
+18.48% |
| 2013-06-30 | €386.30 Million ≈ $451.63 Million |
+3.21% |
| 2012-06-30 | €374.30 Million ≈ $437.60 Million |
-16.66% |
| 2011-06-30 | €449.10 Million ≈ $525.05 Million |
-5.87% |
| 2010-06-30 | €477.10 Million ≈ $557.78 Million |
-6.52% |
| 2009-06-30 | €510.40 Million ≈ $596.71 Million |
+12.92% |
| 2008-06-30 | €452.00 Million ≈ $528.44 Million |
-45.05% |
| 2007-06-30 | €822.50 Million ≈ $961.59 Million |
+165.75% |
| 2006-06-30 | €309.50 Million ≈ $361.84 Million |
+9.91% |
| 2005-06-30 | €281.60 Million ≈ $329.22 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ramsay Generale De Sante's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 297.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €82.70 Million | 7.22% |
| Other Components | €1.12 Billion | 97.50% |
| Total Equity | €1.15 Billion | 100.00% |
Ramsay Generale De Sante Competitors by Market Cap
The table below lists competitors of Ramsay Generale De Sante ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vizsla Silver Corp.
TO:VZLA
|
$1.18 Billion |
|
GeneDx Holdings Corp.
NASDAQ:WGS
|
$1.18 Billion |
|
United States Steel Corp
BA:X
|
$1.18 Billion |
|
Shanghai Jinqiao Export Processing Zone Development Co Ltd A
SHG:600639
|
$1.18 Billion |
|
Ami Organics Limited
NSE:AMIORG
|
$1.18 Billion |
|
Zensar Technologies Limited
NSE:ZENSARTECH
|
$1.18 Billion |
|
Guangzhou Wondfo Biotech Co Ltd
SHE:300482
|
$1.17 Billion |
|
HBM HLDGS LTD DL-000025
F:6XY
|
$1.17 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ramsay Generale De Sante's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,194,300,000 to 1,145,200,000, a change of -49,100,000 (-4.1%).
- Net loss of 54,100,000 reduced equity.
- Other comprehensive income decreased equity by 554,300,000.
- Other factors increased equity by 559,300,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-54.10 Million | -4.72% |
| Other Comprehensive Income | €-554.30 Million | -48.4% |
| Other Changes | €559.30 Million | +48.84% |
| Total Change | €- | -4.11% |
Book Value vs Market Value Analysis
This analysis compares Ramsay Generale De Sante's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.06x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.67x to 1.06x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-06-30 | €6.62 | €11.05 | x |
| 2006-06-30 | €7.10 | €11.05 | x |
| 2007-06-30 | €14.98 | €11.05 | x |
| 2008-06-30 | €7.42 | €11.05 | x |
| 2009-06-30 | €8.45 | €11.05 | x |
| 2010-06-30 | €7.81 | €11.05 | x |
| 2011-06-30 | €7.22 | €11.05 | x |
| 2012-06-30 | €5.95 | €11.05 | x |
| 2013-06-30 | €6.15 | €11.05 | x |
| 2014-06-30 | €7.34 | €11.05 | x |
| 2015-06-30 | €4.85 | €11.05 | x |
| 2016-06-30 | €4.91 | €11.05 | x |
| 2017-06-30 | €5.65 | €11.05 | x |
| 2018-06-30 | €6.19 | €11.05 | x |
| 2019-06-30 | €11.78 | €11.05 | x |
| 2020-06-30 | €9.17 | €11.05 | x |
| 2021-06-30 | €9.70 | €11.05 | x |
| 2022-06-30 | €10.98 | €11.05 | x |
| 2023-06-30 | €11.29 | €11.05 | x |
| 2024-06-30 | €10.86 | €11.05 | x |
| 2025-06-30 | €10.38 | €11.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ramsay Generale De Sante utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.03%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 5.97x
- Recent ROE (-4.72%) is below the historical average (8.14%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 9.83% | 2.19% | 1.06x | 4.25x | €-460.00K |
| 2006 | 13.52% | 2.85% | 0.99x | 4.79x | €10.65 Million |
| 2007 | 27.69% | 12.94% | 0.91x | 2.35x | €144.01 Million |
| 2008 | 10.31% | 2.39% | 0.91x | 4.74x | €1.36 Million |
| 2009 | 17.43% | 4.40% | 0.93x | 4.27x | €37.16 Million |
| 2010 | 9.08% | 2.07% | 1.02x | 4.31x | €-4.31 Million |
| 2011 | 8.65% | 1.97% | 0.98x | 4.46x | €-5.94 Million |
| 2012 | -7.88% | -1.46% | 1.05x | 5.13x | €-64.69 Million |
| 2013 | 14.89% | 2.89% | 1.09x | 4.74x | €18.29 Million |
| 2014 | 24.93% | 5.95% | 1.17x | 3.58x | €66.66 Million |
| 2014 | 6.89% | 1.15% | 1.02x | 5.86x | €-8.91 Million |
| 2015 | 6.69% | 1.15% | 1.00x | 5.83x | €-9.76 Million |
| 2016 | 9.19% | 1.66% | 0.95x | 5.86x | €-3.24 Million |
| 2017 | 12.34% | 2.55% | 0.95x | 5.08x | €10.80 Million |
| 2018 | 1.55% | 0.33% | 0.90x | 5.32x | €-39.72 Million |
| 2019 | 1.54% | 0.45% | 0.78x | 4.38x | €-84.27 Million |
| 2020 | 1.85% | 0.50% | 0.56x | 6.63x | €-82.55 Million |
| 2021 | 6.07% | 1.62% | 0.60x | 6.24x | €-42.03 Million |
| 2022 | 9.77% | 2.75% | 0.63x | 5.60x | €-2.84 Million |
| 2023 | 3.97% | 1.05% | 0.68x | 5.58x | €-75.19 Million |
| 2024 | -4.51% | -1.08% | 0.73x | 5.77x | €-173.33 Million |
| 2025 | -4.72% | -1.03% | 0.77x | 5.97x | €-168.62 Million |
Industry Comparison
This section compares Ramsay Generale De Sante's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,275,567,333
- Average return on equity (ROE) among peers: 27.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ramsay Generale De Sante (GDS) | €1.17 Billion | 9.83% | 4.61x | $1.18 Billion |
| Clariane SE (CLARI) | $1.90 Billion | 3.22% | 1.76x | $1.43 Billion |
| EMEIS SA (EMEIS) | $1.89 Billion | 71.75% | 6.36x | $2.24 Billion |
| LNA Sante SA (LNA) | $35.72 Million | 6.56% | 2.09x | $271.76 Million |
About Ramsay Generale De Sante
Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. The company operates medical centres, and mental health day care centres in France; and provides primary medicine, medicine surgery obstetrics (MSO) dialysis, oncology, medical imaging, medical care, follow-up and rehabilitation care, geriatrics, home care and hospitalization, mental health c… Read more